Asst. Prof. FIRAT YERLİKAYA

1. INCREASING THE SOLUBILITY PROPERTIES OF TETRABENAZINE AT BASIC MEDIUM BY USING SOLID DISPERSION TECHNOLOGY TETRABENAZİNİN BAZİK ORTAMDAKİ ÇÖZÜNME ÖZELLİKLERİNİN KATI DİSPERSİYON TEKNOLOJİSİ İLE ARTIRILMASI

Baş H., YERLİKAYA F., Acartürk F.

Ankara Universitesi Eczacilik Fakultesi Dergisi , vol.49, no.2, pp.241-263, 2025 (Scopus, TRDizin)

2. A Novel Method for Development and Validation of the Degradation Products Analysis of N-Carbamylglutamate with UHPLC by Using Design of Experiment Approach

Arabaci B., YERLİKAYA F., BAŞCI AKDUMAN N. E.

ACS Omega , 2024 (SCI-Expanded, Scopus)

3. Determination of Caffeine in Human Plasma by Using Liquid Chromatography-Tandem Mass Spectrometry

YERLİKAYA F., SAĞLAM O.

Cumhuriyet Science Journal , vol.44, no.3, pp.485-490, 2023 (TRDizin)

4. The Bioequivalence Study of Two Dexketoprofen 25 mg Film-Coated Tablet Formulations in Healthy Males Under Fasting Conditions

YERLİKAYA F., Arslan A., Baş H., Sağlam O., Aytaç S. P.

Turkish Journal of Pharmaceutical Sciences , vol.20, no.2, pp.115-120, 2023 (ESCI, Scopus, TRDizin)

5. The Relative Bioavailability Study of Two Cefdinir Formulations in Healthy Males Under Fasting Conditions

YERLİKAYA F., ARSLAN A., Atik O., Kozan S., Parlak A., Özel Karataş M., et al.

FABAD Journal of Pharmaceutical Sciences , vol.48, no.1, pp.25-36, 2023 (Scopus, TRDizin)

6. The Bioequivalence Study of Two Cefdinir 250 mg/5 mL Oral Suspension Formulations in Healthy Males Under Fasting Conditions

YERLİKAYA F., Arslan A., Atik Ö., Kozan S., Parlak A., Özel Karataş M., et al.

Hacettepe University Journal of the Faculty of Pharmacy , vol.43, no.1, pp.43-49, 2023 (Scopus)

7. APPLICATION OF PLACKETT-BURMAN DESIGN FOR DEVELOPMENT AND EVALUATION OF A BETAMETHASONE SUSPENSION FOR INJECTION FORMULATION BİR BETAMETAZON ENJEKSİYONLUK SÜSPANSİYON FORMÜLASYONUNUN GELİŞTİRİLMESİ VE DEĞERLENDİRİLMESİ İÇİN PLACKETT-BURMAN TASARIMININ UYGULANMASI

YERLİKAYA F., Arslan A., Arabaci B., Gençer P., NEMUTLU E.

Ankara Universitesi Eczacilik Fakultesi Dergisi , vol.47, no.2, pp.477-489, 2023 (Scopus, TRDizin)

8. Development of paclitaxel and flurbiprofen co-loaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett-Burman design

Sahin A., Caban-Toktas S., Tonbul H., Yerlikaya F., AKTAŞ Y., ÇAPAN Y.

ISTANBUL JOURNAL OF PHARMACY , vol.49, no.3, pp.161-166, 2019 (ESCI, TRDizin) Sustainable Development

9. Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles

Kozlu S., Sahin A., Ultav G., Yerlikaya F., ÇALIŞ S., ÇAPAN Y.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.45, pp.213-219, 2018 (SCI-Expanded, Scopus) Sustainable Development

10. Development and validation of a stability-indicating ultra-performance liquid chromatography (UPLC) method for doxycycline hyclate: An optimization of the analytical methodology for a medical countermeasure (MCM) drug

Mohammad A., Yen C. H., Schneider M., Lowry B., YERLİKAYA F., Whitesell G., et al.

Analytical Methods , vol.10, no.16, pp.1842-1851, 2018 (SCI-Expanded, Scopus)

11. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery

ŞAHİN A., ESENDAĞLI G., YERLİKAYA F., Caban-Toktas S., Yoyen-Ermis D., HORZUM U., et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , vol.45, no.8, pp.1657-1664, 2017 (SCI-Expanded, Scopus)

12. A Comparative Evaluation of Polystyrene Divinylbenzene Copolymer HPLC Columns on the Chromatographic Performance of the Compendial Method for Doxycycline Hyclate Capsules: Implications for Method Implementation of a Medical Countermeasure Medication

YERLİKAYA F., Mohammad A., Faustino P., Khan M. A., Saeed K.

Journal of Analytical Sciences, Methods and Instrumentation , vol.5, no.3, pp.23-34, 2015 (Peer-Reviewed Journal)

13. Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments

Xu X., Al-Ghabeish M., Rahman Z., Krishnaiah Y. S., YERLİKAYA F., Yang Y., et al.

International Journal of Pharmaceutics , vol.493, no.1-2, pp.412-425, 2015 (SCI-Expanded, Scopus)

14. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

Yerlikaya F., Ozgen A., VURAL İ., Guven O., Karaagaoglu E., Khan M. A., et al.

JOURNAL OF PHARMACEUTICAL SCIENCES , vol.102, no.10, pp.3748-3761, 2013 (SCI-Expanded, Scopus)

15. Formulation and In Vitro Evaluation of Paclitaxel Loaded Nanoparticles

Aygul G., YERLİKAYA F., CabanToktas S., Vural I., Capan Y.

Hacettepe University Journal of the Faculty of Pharmacy , vol.33, no.1, pp.25-40, 2013 (Scopus)

16. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles

ÖZTÜRK K., Caban S., Kozlu S., Kadayifci E., YERLİKAYA F., ÇAPAN Y.

Pharmazie , vol.65, no.9, pp.665-669, 2010 (SCI-Expanded, Scopus)

17. LC-UV Determination of Melatonin from Chitosan Nanoparticles

Yerlikaya F., Aktas Y., ÇAPAN Y.

CHROMATOGRAPHIA , vol.71, pp.967-970, 2010 (SCI-Expanded, Scopus)

Asst. Prof. FIRAT YERLİKAYA

Publications & Works

1. INCREASING THE SOLUBILITY PROPERTIES OF TETRABENAZINE AT BASIC MEDIUM BY USING SOLID DISPERSION TECHNOLOGY TETRABENAZİNİN BAZİK ORTAMDAKİ ÇÖZÜNME ÖZELLİKLERİNİN KATI DİSPERSİYON TEKNOLOJİSİ İLE ARTIRILMASI

2. A Novel Method for Development and Validation of the Degradation Products Analysis of N-Carbamylglutamate with UHPLC by Using Design of Experiment Approach

3. Determination of Caffeine in Human Plasma by Using Liquid Chromatography-Tandem Mass Spectrometry

4. The Bioequivalence Study of Two Dexketoprofen 25 mg Film-Coated Tablet Formulations in Healthy Males Under Fasting Conditions

5. The Relative Bioavailability Study of Two Cefdinir Formulations in Healthy Males Under Fasting Conditions

6. The Bioequivalence Study of Two Cefdinir 250 mg/5 mL Oral Suspension Formulations in Healthy Males Under Fasting Conditions

7. APPLICATION OF PLACKETT-BURMAN DESIGN FOR DEVELOPMENT AND EVALUATION OF A BETAMETHASONE SUSPENSION FOR INJECTION FORMULATION BİR BETAMETAZON ENJEKSİYONLUK SÜSPANSİYON FORMÜLASYONUNUN GELİŞTİRİLMESİ VE DEĞERLENDİRİLMESİ İÇİN PLACKETT-BURMAN TASARIMININ UYGULANMASI

8. Development of paclitaxel and flurbiprofen co-loaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett-Burman design

9. Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles

10. Development and validation of a stability-indicating ultra-performance liquid chromatography (UPLC) method for doxycycline hyclate: An optimization of the analytical methodology for a medical countermeasure (MCM) drug

11. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery

12. A Comparative Evaluation of Polystyrene Divinylbenzene Copolymer HPLC Columns on the Chromatographic Performance of the Compendial Method for Doxycycline Hyclate Capsules: Implications for Method Implementation of a Medical Countermeasure Medication

13. Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments

14. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

15. Formulation and In Vitro Evaluation of Paclitaxel Loaded Nanoparticles

16. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles

17. LC-UV Determination of Melatonin from Chitosan Nanoparticles

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Sum Other)

Project

Intellectual Property

Thesis Advisory

Open Access